Financing Quarterly Statistics, Q3 2024
A Look At Financing Activity Across The Biopharma, Medical Device And In Vitro Diagnostics Industries, July-Sept 2024
During Q3, biopharmas brought in an aggregate $17bn in financing and device company fundraising totaled $3bn; while in vitro diagnostic firms and research tools players raised $1.1m.
